glaucome ppt

Embed Size (px)

Citation preview

  • 7/24/2019 glaucome ppt

    1/15

    Glaucoma

  • 7/24/2019 glaucome ppt

    2/15

    What is glaucoma?

    Optic neuropathy that is the leading cause ofirreversible blindness in the world

    Major types are open angle and closed angle

    Differences among various types of glaucomacomplicate the nomenclature

    Glaucoma is commonly associated with elevated

    intraocular pressure (IOP) but the disease can occur inthe conte!t of normal IOP

    Our understanding and treatment of the disease is very

    focused on IOP

  • 7/24/2019 glaucome ppt

    3/15

    From www.ahaf.org

  • 7/24/2019 glaucome ppt

    4/15

    Case 1

    Mr" # presents to you with diminished peripheral vision" $e

    complains that he feels li%e the world is closing in on him" $e also

    notes that he has trouble loo%ing at lights as they all appear to be

    surrounded by halos" &ou perform fundoscopic and gonioscopic

    e!am with tonometry and diagnose glaucoma"

  • 7/24/2019 glaucome ppt

    5/15

    Open Angle Glaucoma

    From http://www.merckfrosst.ca/e/health/glaucoma/glaucoma/classify/home.html

    Obstruction at the level of the

    trabecular meshwor%

    Progressive loss of visual field

    over time from periphery to

    center

    Presence of hollowed out optic

    disc ('cupping) due to retinal

    ganglion cell death

    Open anterior chamber angle

    Majority of patients have IOP

    *+ mm$g asymptomatic

  • 7/24/2019 glaucome ppt

    6/15

    Case 2

    Mrs" P is a ,- yr" old female who has become acutely ill in the

    waiting room" .n ophthalmologic assistant had dilated her eyes in

    preparation for e!amination" #he is now complaining of nausea

    diaphoresis and pain in her right eye which is now red and swollen"

  • 7/24/2019 glaucome ppt

    7/15

    Closed Angle Glaucoma

    .pposition of iris andtrabecular meshwor%

    Parasympatholytics

    (pupillary dilation) can

    precipitate attac% Increase ris% with age

    increase in volume of lens

    .cute onset patient

    complains of nausea

    headache (rather than eye

    ache) malaise general

    distress

    /e0uires immediate

  • 7/24/2019 glaucome ppt

    8/15

    BOTTOM LINE: IOP from Aqueous Flow, 3 Sites

    1. Obstructed Trabecular Mesh Open Angle: Age-related, genetic

    Closed Angle: Anatomic,

    exacerbated by:

    2. Pupillary Block Dilation of pupiliris flattens,

    flow via pupil, iris forwardiris-cornea angle

    3. Swelling of Ciliary Body

    1

    2

    3

    SIDENOTE:

    WHYWOULD YOU WANT TO DILATEMRS. Ps PUPILS

    WITHPHENYLEPHRINE VS. ANANTICHOLINERGIC?

    Modified from: Wood et al. NEJM 339:1298 (1998)

  • 7/24/2019 glaucome ppt

    9/15

    REVIEW: Autonomic NS Effect on the Eye

    RECEPTOR ACTIVATION WILL: TO LOWER IOP, AIM FOR:

    IRIS, Circular Fibers mAchR : Constrict Pupil Activity

    IRIS, Radial Fibers 1 R : Dilate Pupil Activity

    CILIARY MUSCLES mAchR : Contract for Accomodation

    2 R : Relax for Far Vision

    Activity

    Activity

    Modified from: http://pharma1.med.osaka-u.ac.jp/textbook/Autonomic/Autonomic.html

  • 7/24/2019 glaucome ppt

    10/15

    TREATMENT RATIONALE

    LOWER IOP BY:

    (1) Decreasing Production of Aqueous Humor

    (2) Increasing Outflow of Aqueous Humor

    Focus onPharmacologi

    c Rx: First-line

  • 7/24/2019 glaucome ppt

    11/15

    DRUGS THAT DECREASE AQUEOUS PRODUCTION

    I. Beta-Blockers[levobunolol, timolol, carteolol, betaxolol]

    -Mechanism: Act on ciliary body to production of aqueous humor -Administration: Topical drops to avoid systemic effects

    -Side Effects: Cardiovascular (bradycardia, asystole, syncope),bronchoconstriction (avoid with 1-selective betaxolol), depression

    II. Alpha-2 Adrenergic Agonists[apraclonidine, brimonidine]

    -Mechanism: production of aqueous humor-Administration: Topical drops

    -Side Effects: Lethargy, fatigue, dry mouth [apraclonidine is a derivative ofclonidine (antihypertensive) which cannot cross BBB to causesystemic hypotension]

    III. Carbonic Anhydrase Inhibitors[acetazolamide, dorzolamide] -Mechanism: Blocks CAII enzyme production of bicarbonate ions

    (transported to posterior chamber, carrying osmotic water flow),thus production of aqueous humor

    -Administration: Oral, topical

    -Side Effects: malaise, kidney stones, possible (rare) aplastic anemia

  • 7/24/2019 glaucome ppt

    12/15

    DRUGS THAT INCREASE AQUEOUS OUTFLOW

    I. Nonspecific Adrenergic Agonists [epinephrine, dipivefrin]

    -Mechanism: uveoscleral outflow of aqueous humor

    -Administration: Topical drops

    -Side Effects: Can precipitate acute attack in patients with narrow iris-corneal angle, headaches, cardiovascular arrhythmia, tachycardia

    II. Parasympathomimetics[pilocarpine, carbachol, echothiophate]

    -Mechanism: contractile force of ciliary body muscle, outflow via TM

    -Administration: Topical drops or gel, (slow-release plastic insert)

    -Side Effects: Headache, induced miopia. Few systemic SE for direct-actingagonists vs. AchE inhibitors (diarrhea, cramps, prolonged paralysis insetting of succinylcholine). Why isnt Ach used?

    III. Prostaglandins[latanoprost] -Mechanism: May uveoscleral outflow by relaxing ciliary body muscle

    -Administration: Topical drops

    -Side Effects: Iris color change

  • 7/24/2019 glaucome ppt

    13/15

    LOWERING IOP SLOWS PROGRESSION OF VISUAL LOSS

    IN OPEN ANGLE GLAUCOMA

    1arly Manifest Glaucoma 2rial3

    4+st (ade0uately powered) randomi5ed trial

    with untreated control arm to evaluate effects of IOP reduction in

    patients with open4angle glaucoma"

    42reatment significantly delayed progression"

  • 7/24/2019 glaucome ppt

    14/15

    Rx GLAUCOMA: ADDITIONAL CONSIDERATIONS

    1. No single medication can be used in all patients

    2. Compliance- Critical: Rx often requires several agents,

    multiple times a day, everyday

    - Role of slow-release drug delivery devices (Langer)

    3. Non-pharmacologic ways to lower IOP:- Laser (argon laser trabeculoplasty)

    - aqueous outflow, loses effectiveness over time- Surgical (trabeculectomy)

    - Creates alternative path for aqueous outflow- Only definitive therapy for closed angle

    4. Effectiveness of Rx measured by ability to lower IOP, but

    other factors may be (more) important:

    - Neuroprotection/increased blood flow to optic nerve

  • 7/24/2019 glaucome ppt

    15/15

    GLAUCOMA: Key Points

    Glaucoma: -Visual loss from optic neuropathy

    -Open angle chronic, Closed angle acute

    -Final common pathway: IOP (usually)

    Drug Rx: -All directed towardsIOP either via: - aqueous production: Beta blockers

    Alpha-2 agonists Carbonic anhydrase inhibitors

    - aqueous outflow: (Adrenergic agonists, nonspecific) Parasympathomimetics

    Prostaglandins Treatment slows progression

    Understanding ANS effect on the eye is critical for reasoning throughdrug mechanisms of action

    Understanding ANS effect on the whole body is critical for predictingand avoiding dangerous side effects